Novartis leadership will be at the World Economic Forum (WEF) Annual Meeting
January 16-20, 2023 | Davos, Switzerland
Our focus at WEF is to explore how more people can have access to transformative treatments, faster.
We will highlight the various ways this can be achieved at systemic levels across some of the world's toughest healthcare challenges.
Future of Health Systems
Our thought-leadership and actions are industry leading.
Here are a some of the systemic ways we are reimagining medicine to improve and extend people's lives
The future of medicine is here
Vas Narasimhan, LinkedIn article
Why the pharmaceutical industry must partner with public healthcare to improve patient health
Marie-France Tschudin, President, Innovative Medicines International and Chief Commercial Officer
Urban population health initiative delivers significant reductions in heart disease
CARDIO4Cities, Novartis Foundation
Tackling health poverty risks in Africa: 4 experts weigh in
Lutz Hegemann, President, Global Health and Sustainability, Novartis
..looking towards a healthier future within reach, we know business is key to translating science into widespread human progress.
Public health systems and pharmaceutical companies are at a crossroads. Both must adapt and re-focus on patients.
Conducting business with integrity is of paramount importance and, as a focused medicines company, essential to our patients, partners and associates.
Heart disease and the need for more equitable healthcare systems are two such issues which require our attention to make the world a better and more sustainable place.
Public-private partnerships are essential to driving investments in high-quality healthcare, medicines, services and innovations required to build resilient and equitable health systems.
It's important to start with the right problem statement in all aspects of health, but specifically in population health.
Events and Panels
The Future of Health: Unlocking the power of data to improve urban health
January 17, 2023 14:00 CET
Live WEF Panel
hosted by Novartis Foundation
Meet the Leaders Podcast: Marie-France Tschudin
World Economic Forum Podcast
Health Equity as an Essential Component of Stakeholder Capitalism
January 18, 2023 14:30 CET
Live WEF Panel
hosted by Deloitte
In the News
Novartis CEO says Covid to become endemic, calls for better pandemic preparedness
“I think what we’re going to settle into is more of an endemic environment with respect to coronaviruses and the Covid virus specifically,” Vas Narasimhan, CEO of Novartis, told CNBC at the World Economic Forum in Davos, Switzerland.
Novartis CEO: Nations pulling back on health care spending ‘has long-term consequences'
Novartis CEO Vasant Narasimhan joins Yahoo Finance Live's Julie Hyman at the 2023 World Economic Forum in Davos, Switzerland, to discuss drug pricing, the future of medicine, the impact that health can have on economies, growth, and the outlook for the health care industry.
Through our core business – the discovery, development and marketing of innovative treatments – we have helped prevent and treat diseases, ease suffering and improve quality of life for people worldwide.
Environmental, Social and Governance
At Novartis, we use science-based innovation to address some of society’s most challenging healthcare issues.
Our strategy is to deliver high-value medicines that alleviate society’s greatest disease burdens through technology leadership in R&D and novel access approaches.
Follow our Conversation on Social
Marie-France Tschudin, President, Innovative Medicines International & Chief Commercial Officer: LinkedIn
Klaus Moosmayer, Chief Ethics, Risk & Compliance Officer: LinkedIn